Barely Significant
← all excerpts

Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch.

Alzheimers Res Ther · 2015 · PMC4353453 · PMID 25755685

Europe PMCDOI
1
hedged sentence
0.0580
closest p · 1.2× alpha
0.0580
boldest claim

The sentences

borderline non-significantP = 0.058so close (0.05 < p ≤ 0.1)
At Week 48, a baseline ADCS-IADL score indicating a more severe disease status led to an increased estimate of the probability of no decline ( P = 0.020), while an MMSE score ≤12 at baseline reduced the estimate ( P = 0.040); treatment with the 13.3 mg/24 h versus the 9.5 mg/24 h patch was borderline non-significant ( P = 0.058).

also in 434 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.